U.S. Insurance Stock News

Talen Energy agreed to acquire three natural gas power plants from Energy Capital Partners for $3.45b. The deal expands Talen's generation capacity and footprint in the PJM market, with a focus on serving data centers and large commercial buyers. The transaction includes an equity component that adds Energy Capital Partners as a major shareholder. Regulators have proposed an emergency wholesale electricity auction that could affect revenue visibility for generators such as Talen. Talen...

Why Copart’s upcoming earnings and conference appearance matter Copart (CPRT) heads into its upcoming fiscal second quarter report with investors expecting a low single digit profit decline, after four quarters of meeting or beating earnings estimates and a generally positive analyst stance. That backdrop, together with Copart’s January 14 appearance at the CJS Securities “New Ideas for the New Year” Investor Conference, has kept attention on whether the current share price already reflects...

If you are wondering whether Highwoods Properties is priced fairly right now, you are not alone. Many investors are trying to work out if the current share price reflects its underlying real estate portfolio. The stock last closed at US$27.07, with returns of 0.7% over 7 days, 6.6% over 30 days, 4.6% year to date and an 18.3% gain across 3 years, alongside a 4.9% decline over 1 year and a 3.2% decline over 5 years. This gives a mixed picture of how sentiment has shifted over time. Recent...

ONEOK (NYSE:OKE) is drawing fresh attention as its balance sheet, cash flows, and recent M&A integration are being linked to a mix of value, growth, and income potential. Commentary around the company is focusing on its extensive pipeline and midstream network and the high barriers to entry that come with it. The latest M&A deal is being framed as a source of incremental synergies and scale, adding to ONEOK's perceived resilience in a cautious market. ONEOK sits at the center of North...

Rayonier (NYSE:RYN) has announced that its 2025 dividend distributions will be classified as 100% capital gain distributions for tax purposes. This tax treatment applies to dividends paid during the 2025 tax year and is relevant for shareholders planning their future tax filings. For investors watching Rayonier at a share price of $24.29, this tax update adds another factor to consider alongside recent price moves. The stock is up 5.3% over the past week and 11.5% over the past month, with...

Board change and dividend decision put AGNC’s risk and income trade off in focus AGNC Investment (AGNC) has drawn attention after a period of share price volatility, with investors weighing its high yield against interest rate uncertainty and recent board and dividend decisions. See our latest analysis for AGNC Investment. Those board and dividend announcements landed against a backdrop of a 14.31% 90 day share price return and a 38.91% 1 year total shareholder return. This suggests momentum...

If you are wondering whether Broadridge Financial Solutions is attractively priced right now, you are not alone. Many investors are asking the same question as they look at the recent share performance. The stock closed at US$209.28, with a 5.4% decline over the last 7 days, a 7.4% decline over 30 days and a 5.1% decline year to date, while the 1-year return is a 9.0% decline compared to gains of 46.4% over 3 years and 49.9% over 5 years. Recent news coverage has focused on Broadridge's role...

What the latest numbers say about EastGroup Properties EastGroup Properties (EGP) has been drawing attention after recent share price moves, with a 1 day return of about a 1.2% decline contrasting with gains over the past week, month and past 3 months. See our latest analysis for EastGroup Properties. The recent 1 day share price decline sits against a steadier backdrop, with the share price up over the past month and year to date, while total shareholder returns over 1, 3 and 5 years...

Capricor Therapeutics recently reported that the FDA, after reviewing topline Phase 3 HOPE-3 data for Deramiocel in Duchenne muscular dystrophy, has issued a request for the full clinical study report and supporting data to address a prior Complete Response Letter, without asking for new clinical trials or patient data. The company aims to submit the HOPE-3 report in February 2026, a step that could clarify the regulatory path for this first-in-class cell therapy candidate with multiple...

Viavi Solutions (VIAV) has rolled out new XEdge sensors for private 4G, 5G and Wi-Fi networks alongside an AR-based RF Viewer tool for its OneAdvisor 800 Wireless platform, drawing fresh attention to the stock. See our latest analysis for Viavi Solutions. The recent product launches come as Viavi’s share price, now at $18.64, shows building momentum, with a 90 day share price return of 40.89% and a 1 year total shareholder return of 79.06%, while the 5 year total shareholder return of 12.90%...

Why Warner Bros. Discovery is on investors’ radar today Warner Bros. Discovery (WBD) shares have been drawing attention after a mixed run, with a small 1 day decline and a modest slip over the past week, set against stronger multi month and multi year returns. Investors are weighing that performance alongside the company’s media and streaming footprint, its recent revenue of US$37.9b and net income of US$489m, while also noting annual revenue growth of 0.3% and a 36.7% decline in net...

Philip Morris International (NYSE:PM) is expanding its smoke free portfolio, led by strong consumer uptake of its Zyn nicotine pouch brand in the U.S. The company is deepening its presence in alternative nicotine products, including new partnerships that extend its reach and product visibility. PMI has broadened its branding partnership with Scuderia Ferrari HP, tying its smoke free positioning to a high profile global sports platform. The company is also emphasizing cognitive innovation and...

Earlier this month, Planet Labs PBC announced a multi-year, low nine-figure agreement with the Swedish Armed Forces for sovereign satellites, high-resolution data access, and space-based awareness solutions, marking its third satellite services contract in twelve months. This deal, alongside the forthcoming Owl constellation designed to deliver near-daily one-meter class imagery, reinforces Planet’s role as a key provider of advanced Earth observation infrastructure to allied...

Agnico Eagle Mines (NYSE:AEM) is highlighted as a top precious metals equity pick. Recent analyst downgrades flag higher investment needs and project execution risks. Commentary also reflects a more cautious stance on future commodity demand. These mixed views are drawing attention to the company’s capital plans and risk profile. Agnico Eagle Mines focuses on gold and other precious metals, so its outlook is closely linked to commodity pricing and sector sentiment. The company now sits in a...

If you are wondering whether United Airlines Holdings' share price still represents good value after a strong multi year run, this article walks through what the current market price could be implying. The stock last closed at US$108.57, with returns of a 5.1% decline over 7 days, a 4.8% decline over 30 days, a 3.9% decline year to date and a 1.8% decline over 1 year, set against very large gains over 3 years and 5 years. Recent investor attention has been shaped by sector wide updates,...

If you have been wondering whether Apple Hospitality REIT is attractively priced or just a value trap, this breakdown is designed to help you size up the stock in a clear, practical way. The share price recently closed at US$12.19, with returns of 1.1% year to date but a 13.8% decline over the last year and a 24.5% gain over five years, which gives a mixed picture of how the market has been treating the REIT. Recent headlines around U.S. hotels and travel, including ongoing discussions about...

In January 2026, Tenaya Therapeutics outlined past and upcoming 2026 milestones for its TN-201 and TN-401 gene therapy programs, including interim MyPEAK-1 data, additional RIDGE-1 updates, and plans to seek regulatory alignment on potential pivotal studies. A key insight is that both programs target genetically defined cardiac conditions with U.S. FDA designations and planned data readouts that could clarify each therapy’s clinical risk profile and development path. We will now examine how...

If you are wondering whether Global Payments is starting to look attractive after a rough run, this breakdown will help you weigh what the current share price might really be offering. The stock last closed at US$71.67, with returns of a 7.5% decline over 7 days, an 11.4% decline over 30 days, a 5.1% decline year to date, a 33.2% decline over 1 year, a 34.2% decline over 3 years, and a 59.8% decline over 5 years. Recent headlines have focused on Global Payments' position within the broader...

Crescent Capital Group and Pantheon recently closed Crescent Credit Solutions VII CV, a US$3.20 billion private credit continuation vehicle acquiring a portfolio of performing sponsor-backed loans and related interests from a 2016-vintage Crescent fund, with funds managed by Hamilton Lane committing significant capital. Hamilton Lane’s role as a key investor in this large continuation vehicle highlights its active positioning within the expanding institutional private credit ecosystem. We’ll...

If you are wondering whether Datadog's share price lines up with its business story, or if the stock is pricing in too much hope, you are not alone. After a strong multi year run, the stock is now about 12.5% lower year to date, with a 16.7% decline over the last month and a 6.8% drop in the past week, on top of a 15.5% decline over the last year. This reshapes how some investors may be thinking about its risk and return trade off. Recent headlines have focused on Datadog's position in cloud...

If you are trying to work out whether Axcelis Technologies is still a reasonable entry point or already pricing in a lot of good news, its current valuation story is worth a closer look. The share price recently closed at US$88.16, with returns of 6.6% over the last 30 days and 23.4% over the last year, although the stock has seen a 9.2% decline over the past week and an 18.3% decline over three years, with a 135.5% gain over five years and a 2.4% return year to date. Recent coverage has...

Why GigaCloud Technology (GCT) Is Back on Investors’ Radar Interest in GigaCloud Technology (GCT) has picked up as investors weigh projections for lower year-over-year earnings alongside higher revenue, and consider how estimate revisions align with the upcoming Needham Growth Conference appearance. See our latest analysis for GigaCloud Technology. At a share price of $39.78, GigaCloud Technology has seen a 47.28% 90 day share price return and a very large 3 year total shareholder return...

If you are asking yourself whether Franklin Resources is still good value at around US$24.84 per share, you are not alone. This article is built to answer that question directly. The stock has been relatively steady in the short term, with a 1.7% decline over the last 7 days, a 3.5% gain over the last 30 days, a 4.4% gain year to date and a 32.8% return over the last year, while the 3 year and 5 year returns sit at a 2.7% decline and a 14.5% gain respectively. Recent coverage around asset...

MongoDB (NasdaqGM:MDB) has integrated Voyage AI models into its core platform. The company has launched new embedding and reranking APIs to support AI retrieval. MongoDB introduced an AI assistant for database operations, aimed at production-ready AI workloads. MongoDB, trading at $384.82, is adding AI capabilities directly within its database platform. The stock has seen a 49.2% return over the past year and a 92.5% return over three years, while the year-to-date return is a 3.7% decline...